Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues

Aging and Disease

Volumn 2, Issue 5, 2011, Pages 361-373

  Frasca, Daniela ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Differentiation; Function; Immunity; Lymphoid tissue

Indexed keywords

MURINAE; MUS;

EID: 84869750763     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Hodes RJ (1997). Aging and the immune system. Immunol Rev, 160: 5-8
2. LeMaoult J, Szabo P and Weksler ME (1997). Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev, 160: 115-126
3. Linton PJ and Dorshkind K (2004). Age-related changes in lymphocyte development and function. Nat Immunol, 5: 133-139
4. Mountz JD, Wu J, Zhou T and Hsu HC (1997). Cell death and longevity: implications of Fas-mediated apoptosis in T-cell senescence. Immunol Rev, 160: 19-30
5. Pawelec G and Solana R (1997). Immunosenescence. Immunol Today, 18: 514-516
6. Weiss A and Miller LJ (1998). Halting the march of the immune defenses. Science, 280: 179
7. Ferrucci L, Guralnik JM, Pahor M, Corti MC and Havlik RJ (1997). Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA, 277: 728-734
8. Goidl EA, Innes JB and Weksler ME (1976). Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med, 144: 1037-1048
9. Weksler MC, Innes JD and Goldstein G (1978). Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36. J Exp Med, 148: 996-1006
10. Smith AM (1976). The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol, 116: 469-474
11. Klinman NR and Kline GH (1997). The B-cell biology of aging. Immunol Rev, 160: 103-114
12. Song H, Price PW and Cerny J (1997). Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev, 160: 55-62
13. Zheng B, Han S, Takahashi Y and Kelsoe G (1997). Immunosenescence and germinal center reaction. Immunol Rev, 160: 63-77
14. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL and Swain SL (1999). Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med, 190: 1013-1024
15. Eaton SM, Burns EM, Kusser K, Randall TD and Haynes L (2004). Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med, 200: 1613-1622
16. Maue AC, Eaton SM, Lanthier PA, Sweet KB, Blumerman SL and Haynes L (2009). Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol, 182: 6129-6135
17. Haynes L, Eaton SM, Burns EM, Randall TD and Swain SL (2003). CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A, 100: 15053-15058
18. Shedlock DJ and Shen H (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science, 300: 337-339
19. Sun JC and Bevan MJ (2003). Defective CD8 T cell memory following acute infection without CD4 T cell help. Science, 300: 339-342
20. Kaech SM, Wherry EJ and Ahmed R (2002). Effector and memory T-cell differentiation: implications for vaccine development. Nature reviews, 2: 251-262
21. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM and Weyand CM (2001). Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol, 75: 12182-12187
22. Vallejo AN (2005). CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev, 205: 158-169
23. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G and Solana R (2009). Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res, 21: 201-209
24. Pawelec G, Derhovanessian E, Larbi A, Strindhall J and Wikby A (2009). Cytomegalovirus and human immunosenescence. Rev Med Virol, 19: 47-56
25. Faunce DE, Palmer JL, Paskowicz KK, Witte PL and Kovacs EJ (2005). CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity. J Immunol, 175: 3102-3109
26. Zhao DM, Thornton AM, DiPaolo RJ and Shevach EM (2006). Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood, 107: 3925-3932
27. Lim HW, Hillsamer P, Banham AH and Kim CH (2005). Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol, 175: 4180-4183
28. Sharma S, Dominguez AL and Lustgarten J (2006). High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol, 177: 8348-8355
29. Wick G and Grubeck-Loebenstein B (1997). Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease. Immunol Rev, 160: 171-184
30. Plackett TP, Boehmer ED, Faunce DE and Kovacs EJ (2004). Aging and innate immune cells. J Leukoc Biol, 76: 291-299
31. Aydar Y, Balogh P, Tew JG and Szakal AK (2004). Follicular dendritic cells in aging, a bottle-neck in the humoral immune response. Ageing Res Rev, 3: 15-29
32. Herrero C, Sebastian C, Marques L, Comalada M, Xaus J, Valledor AF, Lloberas J and Celada A (2002). Immunosenescence of macrophages: reduced MHC class II gene expression. Experimental gerontology, 37: 389-394
33. Plowden J, Renshaw-Hoelscher M, Gangappa S, Engleman C, Katz JM and Sambhara S (2004). Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cellular immunology, 229: 86-92
34. Solana R, Pawelec G and Tarazona R (2006). Aging and innate immunity. Immunity, 24: 491-494
35. Pawelec G, Solana R, Remarque E and Mariani E (1998). Impact of aging on innate immunity. J Leukoc Biol, 64: 703-712
36. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J and Sambhara S (2002). Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol, 169: 4697-4701
37. Boehmer ED, Meehan MJ, Cutro BT and Kovacs EJ (2005). Aging negatively skews macrophage TLR2-and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev, 126: 1305-1313
38. Harizi H, Juzan M, Pitard V, Moreau JF and Gualde N (2002). Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol, 168: 2255-2263
39. Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL and Blomberg BB (2007). Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol, 179: 918-927
40. Frasca D, Romero M, Landin AM, Diaz A, Riley RL and Blomberg BB (2010). Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38MAPK/tristetraprolin dephosphorylation and E47 mRNA instability. Mech Ageing Dev, 131: 306-314
41. Frasca D, Van der Put E, Landin AM, Gong D, Riley RL and Blomberg BB (2005). RNA stability of the E2A-encoded transcription factor E47 is lower in splenic activated B cells from aged mice. J Immunol, 175: 6633-6644
42. Frasca D, Van der Put E, Riley RL and Blomberg BB (2004). Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol, 172: 2155-2162
43. Frasca D, Diaz A, Romero M, Landin AM, Phillips M, Lechner SC, Ryan JG and Blomberg BB (2010). Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine, 28: 8077-8084
44. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL and Blomberg BB (2008). Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol, 180: 5283-5290
45. Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, Nilsson BO, Wikby A, Kipling D and Dunn-Walters DK (2009). B-cell diversity decreases in old age and is correlated with poor health status. Aging cell, 8: 18-25
46. Alter-Wolf S, Blomberg BB and Riley RL (2009). Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell generation, phenotype, and light chain expression. J Immunol, 182: 138-147
47. Miller JP and Allman D (2003). The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol, 171: 2326-2330
48. Sherwood EM, Blomberg BB, Xu W, Warner CA and Riley RL (1998). Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment. J Immunol, 161: 4472-4475
49. Guerrettaz LM, Johnson SA and Cambier JC (2008). Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A, 105: 11898-11902
50. Miller JP and Cancro MP (2007). B cells and aging: balancing the homeostatic equation. Experimental gerontology, 42: 396-399
51. Van der Put E, Sherwood EM, Blomberg BB and Riley RL (2003). Aged mice exhibit distinct B cell precursor phenotypes differing in activation, proliferation and apoptosis. Experimental gerontology, 38: 1137-1147
52. McKenna RW, Washington LT, Aquino DB, Picker LJ and Kroft SH (2001). Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood, 98: 2498-2507
53. Rossi MI, Yokota T, Medina KL, Garrett KP, Comp PC, Schipul AH, Jr. and Kincade PW (2003). B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood, 101: 576-584
54. Franceschi C, Monti D, Sansoni P and Cossarizza A (1995). The immunology of exceptional individuals: the lesson of centenarians. Immunol Today, 16: 12-16
55. Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K and Agematsu K (2005). Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol, 175: 3262-3267
56. Chong Y, Ikematsu H, Yamaji K, Nishimura M, Nabeshima S, Kashiwagi S and Hayashi J (2005). CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int Immunol, 17: 383-390
57. Frasca D, Diaz A, Romero M, Landin AM and Blomberg BB (2011). Age effects on B cells and humoral immunity in humans. Ageing Res Rev, 10: 330-335
58. Bulati M, Buffa S, Candore G, Caruso C, Dunn-Walters DK, Pellicano M, Wu YC and Colonna Romano G (2011). B cells and immunosenescence: a focus on IgG+IgD-CD27-(DN) B cells in aged humans. Ageing Res Rev, 10: 274-284
59. Colonna-Romano G, Bulati M, Aquino A, Scialabba G, Candore G, Lio D, Motta M, Malaguarnera M and Caruso C (2003). B cells in the aged: CD27, CD5, and CD40 expression. Mechanisms of ageing and development, 124: 389-393
60. Johnson KM, Owen K and Witte PL (2002). Aging and developmental transitions in the B cell lineage. Int Immunol, 14: 1313-1323
61. Kline GH, Hayden TA and Klinman NR (1999). B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol, 162: 3342-3349
62. Labrie JE, 3rd, Sah AP, Allman DM, Cancro MP and Gerstein RM (2004). Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med, 200: 411-423
63. Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK and Blomberg BB (2009). B cells and aging: molecules and mechanisms. Trends Immunol, 30: 313-318
64. Johnson SA, Rozzo SJ and Cambier JC (2002). Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol, 168: 5014-5023
65. Weksler ME (2000). Changes in the B-cell repertoire with age. Vaccine, 18: 1624-1628
66. Birjandi SZ, Ippolito JA, Ramadorai AK and Witte PL (2011). Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol, 186: 3441-3451
67. Hao Y, O'Neill PJ, Naradikian MS, Scholz JL and Cancro MP (2011). A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood
68. Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW and Marrack P (2011). TLR7-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood
69. Manz RA, Thiel A and Radbruch A (1997). Lifetime of plasma cells in the bone marrow. Nature, 388: 133-134
70. Han S, Yang K, Ozen Z, Peng W, Marinova E, Kelsoe G and Zheng B (2003). Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol, 170: 1267-1273
71. Miller C and Kelsoe G (1995). Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol, 155: 3377-3384
72. Rogerson BJ, Harris DP, Swain SL and Burgess DO (2003). Germinal center B cells in Peyer's patches of aged mice exhibit a normal activation phenotype and highly mutated IgM genes. Mech Ageing Dev, 124: 155-165
73. Yang X, Stedra J and Cerny J (1996). Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med, 183: 959-970
74. Nussenzweig MC and Alt FW (2004). Antibody diversity: one enzyme to rule them all. Nature medicine, 10: 1304-1305
75. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K and Honjo T (2002). The AID enzyme induces class switch recombination in fibroblasts. Nature, 416: 340-345
76. Muramatsu M, Nagaoka H, Shinkura R, Begum NA and Honjo T (2007). Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Advances in immunology, 94: 1-36
77. Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T and Neuberger MS (2002). Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol, 12: 1748-1755
78. Sayegh CE, Quong MW, Agata Y and Murre C (2003). E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol, 4: 586-593
79. Ephrussi A, Church GM, Tonegawa S and Gilbert W (1985). B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science, 227: 134-140
80. Henthorn P, Kiledjian M and Kadesch T (1990). Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science, 247: 467-470
81. Quong MW, Romanow WJ and Murre C (2002). E protein function in lymphocyte development. Annu Rev Immunol, 20: 301-322
82. Kee BL, Bain G and Murre C (2002). IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. Embo J, 21: 103-113
83. Massari ME and Murre C (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol, 20: 429-440
84. Murre C, McCaw PS and Baltimore D (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell, 56: 777-783
85. Schlissel M, Voronova A and Baltimore D (1991). Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev, 5: 1367-1376
86. Sigvardsson M, O'Riordan M and Grosschedl R (1997). EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity, 7: 25-36
87. Frasca D, Riley RL and Blomberg BB (2007). Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Experimental gerontology, 42: 192-203
88. Michael N, Shen HM, Longerich S, Kim N, Longacre A and Storb U (2003). The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity, 19: 235-242
89. Schoetz U, Cervelli M, Wang YD, Fiedler P and Buerstedde JM (2006). E2A expression stimulates Ig hypermutation. J Immunol, 177: 395-400
90. Wang L, Wuerffel R and Kenter AL (2006). NF-kappa B binds to the immunoglobulin S gamma 3 region in vivo during class switch recombination. European journal of immunology, 36: 3315-3323
91. Gonda H, Sugai M, Nambu Y, Katakai T, Agata Y, Mori KJ, Yokota Y and Shimizu A (2003). The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med, 198: 1427-1437
92. Nutt SL, Heavey B, Rolink AG and Busslinger M (1999). Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature, 401: 556-562
93. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K and Staudt LM (2002). Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity, 17: 51-62
94. Kee BL and Murre C (1998). Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med, 188: 699-713
95. O'Riordan M and Grosschedl R (1999). Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity, 11: 21-31
96. Anspach J, Poulsen G, Kaattari I, Pollock R and Zwollo P (2001). Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice. J Immunol, 166: 2617-2626
97. Tell G, Zecca A, Pellizzari L, Spessotto P, Colombatti A, Kelley MR, Damante G and Pucillo C (2000). An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res, 28: 1099-1105
98. Van der Put E, Frasca D, King AM, Blomberg BB and Riley RL (2004). Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J Immunol, 173: 818-827
99. Chen CY and Shyu AB (1995). AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci, 20: 465-470
100. Stoecklin G and Anderson P (2006). Posttranscriptional mechanisms regulating the inflammatory response. Advances in immunology, 89: 1-37
101. Brooks SA, Connolly JE and Rigby WF (2004). The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol, 172: 7263-7271
102. Tchen CR, Brook M, Saklatvala J and Clark AR (2004). The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem, 279: 32393-32400
103. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J and Clark AR (2006). Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol, 26: 2408-2418
104. Cao H, Tuttle JS and Blackshear PJ (2004). Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein. J Biol Chem, 279: 21489-21499
105. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A and Gaestel M (2006). Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol, 26: 2399-2407
106. Landin AM, Frasca D, Harrison P, Scallan M, Riley RL and Blomberg BB (2011). E47 retroviral rescue of intrinsic B-cell defects in senescent mice. Aging cell, 10: 327-337
107. Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D and De Benedictis G (2000). The network and the remodeling theories of aging: historical background and new perspectives. Experimental gerontology, 35: 879-896
108. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C and Passeri M (2008). The immune system in extreme longevity. Experimental gerontology, 43: 61-65
109. Menard LC, Minns LA, Darche S, Mielcarz DW, Foureau DM, Roos D, Dzierszinski F, Kasper LH and Buzoni-Gatel D (2007). B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol, 179: 4857-4866
110. Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD and Garvy BA (2006). B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol, 176: 6147-6154
111. Wojciechowski W, Harris DP, Sprague F, Mousseau B, Makris M, Kusser K, Honjo T, Mohrs K, Mohrs M, Randall T and Lund FE (2009). Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity, 30: 421-433
112. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D and Perry VH (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology, 73: 768-774
113. Isaacs JD (2009). Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists. Expert Opin Biol Ther, 9: 1463-1475
114. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L and Agardh CD (2008). Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One, 3: e2546
115. Mundy GR (2007). Osteoporosis and inflammation. Nutr Rev, 65: S147-151
116. Sarzi-Puttini P, Atzeni F, Doria A, Iaccarino L and Turiel M (2005). Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus, 14: 780-784
117. Chorinchath BB, Kong LY, Mao L and McCallum RE (1996). Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol, 156: 1525-1530
118. Biagi E, Candela M, Franceschi C and Brigidi P (2011). The aging gut microbiota: New perspectives. Ageing Res Rev, in press
119. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkila J, Monti D, Satokari R, Franceschi C, Brigidi P and De Vos W (2010). Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5: e10667
120. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP and O'Toole PW (2010). Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A, 108 Suppl 1: 4586-4591
121. Fujihashi K and Kiyono H (2009). Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol, 30: 334-343
122. Kawanishi H and Kiely J (1989). Immune-related alterations in aged gut-associated lymphoid tissues in mice. Dig Dis Sci, 34: 175-184
123. Koga T, McGhee JR, Kato H, Kato R, Kiyono H and Fujihashi K (2000). Evidence for early aging in the mucosal immune system. J Immunol, 165: 5352-5359
124. Schmucker DL, Daniels CK, Wang RK and Smith K (1988). Mucosal immune response to cholera toxin in ageing rats. I. Antibody and antibody-containing cell response. Immunology, 64: 691-695
125. Taylor LD, Daniels CK and Schmucker DL (1992). Ageing compromises gastrointestinal mucosal immune response in the rhesus monkey. Immunology, 75: 614-618
126. Enioutina EY, Visic VD and Daynes RA (2000). Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine, 18: 2381-2393
127. Krieg AM and Davis HL (2001). Enhancing vaccines with immune stimulatory CpG DNA. Curr Opin Mol Ther, 3: 15-24
128. Alignani D, Maletto B, Liscovsky M, Ropolo A, Moron G and Pistoresi-Palencia MC (2005). Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J Leukoc Biol, 77: 898-905
129. Maletto B, Ropolo A, Moron V and Pistoresi-Palencia MC (2002). CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. J Leukoc Biol, 72: 447-454
130. Manning BM, Enioutina EY, Visic DM, Knudson AD and Daynes RA (2001). CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice. Experimental gerontology, 37: 107-126
131. Fukuiwa T, Sekine S, Kobayashi R, Suzuki H, Kataoka K, Gilbert RS, Kurono Y, Boyaka PN, Krieg AM, McGhee JR and Fujihashi K (2008). A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine, 26: 4849-4859
132. Ershler WB (1993). Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc, 41: 176-181
133. Fujihashi K, McGhee JR, Lue C, Beagley KW, Taga T, Hirano T, Kishimoto T, Mestecky J and Kiyono H (1991). Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest, 88: 248-252
134. Hagiwara Y, McGhee JR, Fujihashi K, Kobayashi R, Yoshino N, Kataoka K, Etani Y, Kweon MN, Tamura S, Kurata T, Takeda Y and Kiyono H (2003). Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue. J Immunol, 170: 1754-1762
135. Daniels CK, Perez P and Schmucker DL (1993). Alterations in CD8+ cell distribution in gut-associated lymphoid tissues (GALT) of the aging Fischer 344 rat: a correlated immunohistochemical and flow cytometric analysis. Experimental gerontology, 28: 549-555
136. Aspinall R and Andrew D (2000). Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine, 18: 1629-1637
137. Frasca D, Pucci S, Goso C, Barattini P, Barile S, Pioli C and Doria G (1997). Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells. Mech Ageing Dev, 93: 157-169
138. Haynes L, Eaton SM and Swain SL (2000). The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine, 18: 1649-1653
139. Klinman DM, Conover J, Bloom ET and Weiss W (1998). Immunogenicity and efficacy of a DNA vaccine in aged mice. J Gerontol A Biol Sci Med Sci, 53: B281-286
140. Agren LC, Ekman L, Lowenadler B and Lycke NY (1997). Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J Immunol, 158: 3936-3946
141. O'Hagan DT, Rappuoli R, De Gregorio E, Tsai T and Del Giudice G (2011). MF59 adjuvant: the best insurance against influenza strain diversity. Expert Rev Vaccines, 10: 447-462
142. Garcon N (2010). Preclinical development of AS04. Methods Mol Biol, 626: 15-27